Emerson Investment Management’s AbbVie ABBV Stock Holding History

Emerson Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$371K	Hold	6,493	–	–	0.07%	110
2015 Q4	$385K	Sell	6,493 -420	-6%	-$24.2K	0.08%	104
2015 Q3	$376K	Buy	6,913 +100	+1%	+$6.51K	0.08%	103
2015 Q2	$458K	Buy	6,813 +20	+0.3%	+$1.31K	0.09%	106
2015 Q1	$398K	Sell	6,793 -250	-4%	-$15.1K	0.07%	116
2014 Q4	$461K	Hold	7,043	–	–	0.09%	113
2014 Q3	$407K	Sell	7,043 -240	-3%	-$13.3K	0.08%	121
2014 Q2	$411K	Sell	7,283 -150	-2%	-$7.87K	0.08%	122
2014 Q1	$382K	Sell	7,433 -70,694	-90%	-$3.57M	0.08%	115
2013 Q4	$4.13M	Sell	78,127 -1,279	-2%	-$62.9K	0.87%	42
2013 Q3	$3.55M	Sell	79,406 -1,016	-1%	-$45K	0.8%	47
2013 Q2	$3.33M	Buy	+80,422	New	+$3.52M	0.77%	46

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerson Investment Management's ABBV Position: Q1 2016 in Review

Emerson Investment Management held its AbbVie (ABBV) position steady in Q1 2016 at 6,493 shares worth $371K. The position accounts for 0.07% of the portfolio, ranked #110.

Emerson Investment Management first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. The position peaked at $4.13M in Q4 2013. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Emerson Investment Management held 6,493 shares of AbbVie worth $371K as of Q1 2016.
Emerson Investment Management left its AbbVie share count unchanged in Q1 2016.
AbbVie made up 0.07% of Emerson Investment Management's portfolio in Q1 2016, its #110 holding.
Emerson Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
Emerson Investment Management's AbbVie position peaked at $4.13M in Q4 2013.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Emerson Investment Management's 13F filing for Q1 2016, filed 9 May 2016.